Gralise ER 300 MG tablet 90S

Ended Awarded

Contract number
SPE2DB24FEABE
Awardee
Awarding agency
Obligated
$4,579

Award facts

Contract value 100% obligated
$4,578.64 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The U.S. Defense Logistics Agency (DLA) awarded a $4,578.64 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GRALISE ER 300 MG TABLET 90S. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion by September 18, 2024.

Quick answers

Who was awarded contract SPE2DB24FEABE?

SPE2DB24FEABE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2024.

How much is contract SPE2DB24FEABE worth?

The government has obligated $4,579 on SPE2DB24FEABE.

Is contract SPE2DB24FEABE an order under another contract?

Yes. SPE2DB24FEABE is a delivery order under SPE2DB24D2205, an indefinite delivery contract.

Was contract SPE2DB24FEABE competed?

The extent of competition for SPE2DB24FEABE was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login